B
Market Data
$220.77+$18.58 (+9.19%)
BIIB · Last trade
Prev Close
$202.19
Range (29d)
$200.14 – $221.56
Recent Filings
- SCHEDULE 13G/A11.9 KBBIOGEN INC.Aug 6, 10:17 AM ET·0000315066-26-001959
- 1445.2 KBBIOGEN INC.Aug 4, 11:22 AM ET·0001959173-26-005582
- 1444.6 KBBIOGEN INC.Aug 3, 1:02 PM ET·0001959173-26-005518
- 10-Q17.0 MBBIOGEN INC.Jul 29, 6:36 AM ET·0000875045-26-000075
- 8-K784.6 KBBIOGEN INC.Jul 29, 6:10 AM ET·0000875045-26-000073
- 8-K202.6 KBBIOGEN INC.Jul 1, 4:08 PM ET·0000875045-26-000068
- 8-K247.2 KBBIOGEN INC.Jun 10, 4:54 PM ET·0000950157-26-000700
- 8-K/A197.5 KBBIOGEN INC.Jun 10, 4:49 PM ET·0000950157-26-000699
- SCHEDULE 13D/A9.1 KBApellis Pharmaceuticals, Inc.May 14, 4:36 PM ET·0000950157-26-000611
- 8-K1.1 MBBIOGEN INC.May 14, 8:31 AM ET·0001193125-26-222908
Insiders
10- ADELMAN BURT AEVP, Portfolio Strategy
- ALEXANDER SUSAN HEVP Chief Legal Officer
- BELZER ALANDirector
- BEST LAWRENCE CDirector
- BUCKNUM THOMAS JEVP and General Counsel
- CAPELLO JEFFREY DEVP & Chief Financial Officer
- Clancy Paul JExecutive VP and CFO
- COVINO GREGORY FVP, Chief Accounting Officer
- Cox JohnEVP Pharmaceutical Oper & Tech
- DEKKERS MARIJN EDirector
Tickers
Addresses
business
225 BINNEY STREET
CAMBRIDGE, MA, 02142
mailing
225 BINNEY STREET
CAMBRIDGE, MA, 02142
Former Names
- BIOGEN IDEC INC.2015-03-20
- BIOGEN IDEC INC2007-04-25
- IDEC PHARMACEUTICALS CORP / DE2003-11-12
- IDEC PHARMACEUTICALS CORP / CA1997-02-14